160 related articles for article (PubMed ID: 1697401)
1. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia.
Schilling PJ; Vadhan-Raj S
N Engl J Med; 1990 Sep; 323(12):833-4. PubMed ID: 1697401
[No Abstract] [Full Text] [Related]
2. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
List AF; Kummet TD; Adams JD; Chun HG
Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
[No Abstract] [Full Text] [Related]
3. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
5. Pulmonary toxicity associated with fludarabine monophosphate.
Hurst PG; Habib MP; Garewal H; Bluestein M; Paquin M; Greenberg BR
Invest New Drugs; 1987; 5(2):207-10. PubMed ID: 2443463
[TBL] [Abstract][Full Text] [Related]
6. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia.
Bastion Y; Coiffier B; Tigaud JD; Espinouse D; Bryon PA
Eur J Cancer; 1991; 27(5):671. PubMed ID: 1711356
[No Abstract] [Full Text] [Related]
8. Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis.
Cervantes F; Salgado C; Montserrat E; Rozman C
Lancet; 1990 Nov; 336(8723):1130. PubMed ID: 1700245
[No Abstract] [Full Text] [Related]
9. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
[TBL] [Abstract][Full Text] [Related]
10. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
Arima N; Mizoguchi H; Shirakawa S; Tomonaga M; Takatsuki K; Ohno R
Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
[TBL] [Abstract][Full Text] [Related]
11. Tumor lysis syndrome induced by fludarabine monophosphate: a case report.
Nakhoul F; Green J; Abassi ZA; Carter A
Eur J Haematol; 1996 Apr; 56(4):254-5. PubMed ID: 8641396
[No Abstract] [Full Text] [Related]
12. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
Pillay GS; Wood L; Jacobs P
S Afr Med J; 1996 Aug; 86(8):949-51. PubMed ID: 8823419
[TBL] [Abstract][Full Text] [Related]
13. [Fludarabine monophosphate in the treatment of patients with advanced stages of chronic B-cell lymphatic leukemia resistant to conventional chemotherapy].
Papajík T; Faber E; Hubácek J; Slezák P; Raida L; Heczko M; Sulovská I; Jarosová M; Pikalová Z; Indrák K
Vnitr Lek; 1997 Jan; 43(1):25-8. PubMed ID: 9221561
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Keating MJ; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs CC; Freireich EJ; McCredie KB
J Clin Oncol; 1991 Jan; 9(1):44-9. PubMed ID: 1702145
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
[No Abstract] [Full Text] [Related]
17. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
[No Abstract] [Full Text] [Related]
18. Fludarabine phosphate--looking forward.
Cheson BD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
[No Abstract] [Full Text] [Related]
19. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
[No Abstract] [Full Text] [Related]
20. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
